Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Sullivan

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Pharmacoeconomics|July 24, 2001
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDST A Lee, S D Sullivan, D L Veenstra, et al.
Allergy|May 19, 2007
Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patientsS D Sullivan, S E Wenzel, B W Bresnahan, et al.
Thorax|July 16, 2008
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPDM Najafzadeh, C A Marra, M Sadatsafavi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment ScenariosM Hoogendoorn, T Feenstra, Y Asukai, et al.
The American Journal of Gastroenterology|August 17, 2004
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis CS D Sullivan, D M Jensen, D E Bernstein, et al.
The European Respiratory Journal|January 2, 2008
Global strategy for asthma management and prevention: GINA executive summaryE D Bateman, S S Hurd, P J Barnes, et al.
The European Respiratory Journal. Supplement|October 30, 2003
The pharmacoepidemiology of COPD: recent advances and methodological discussionP Burney, S Suissa, J B Soriano, et al.
The European Respiratory Journal|February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkersM Cazzola, W MacNee, F J Martinez, et al.
The European Respiratory Journal|September 2, 2008
A new perspective on concepts of asthma severity and controlD R Taylor, E D Bateman, L-P Boulet, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Pharmacoeconomics|July 24, 2001
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDST A Lee, S D Sullivan, D L Veenstra, et al.
Allergy|May 19, 2007
Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patientsS D Sullivan, S E Wenzel, B W Bresnahan, et al.
Thorax|July 16, 2008
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPDM Najafzadeh, C A Marra, M Sadatsafavi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment ScenariosM Hoogendoorn, T Feenstra, Y Asukai, et al.
The American Journal of Gastroenterology|August 17, 2004
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis CS D Sullivan, D M Jensen, D E Bernstein, et al.
The European Respiratory Journal|January 2, 2008
Global strategy for asthma management and prevention: GINA executive summaryE D Bateman, S S Hurd, P J Barnes, et al.
The European Respiratory Journal. Supplement|October 30, 2003
The pharmacoepidemiology of COPD: recent advances and methodological discussionP Burney, S Suissa, J B Soriano, et al.
The European Respiratory Journal|February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkersM Cazzola, W MacNee, F J Martinez, et al.
The European Respiratory Journal|September 2, 2008
A new perspective on concepts of asthma severity and controlD R Taylor, E D Bateman, L-P Boulet, et al.
Pageof 8